$1.91
-0.13-6.37%
At close: -
$1.90
-0.01-0.52%
After Hours: Jan 17, 7:40 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for NLS Pharmaceutics in recent months.
Browse guidance and forecast on all stocks.